Tevogen Bio Holdings Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tevogen Bio Holdings Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2024 to Q2 2025.
  • Tevogen Bio Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $3.24M, a 21.8% decline year-over-year.
  • Tevogen Bio Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $20.8M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $20.8M $3.24M -$903K -21.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $21.7M $7.29M -$19M -72.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $40.8M $6.96M Oct 1, 2024 Dec 31, 2024 10-K 2025-04-02
Q3 2024 $3.33M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $4.14M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $26.3M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.